✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Onyx Biotec Ltd.

ONYX

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹62 Cr.
P/E
12.44

Onyx Biotec Ltd.

  • Onyx Biotec
  • Cohance Lifesciences
  • JB Chem & Pharma

FAQs on Onyx Biotec Ltd. Shareprice

Onyx Biotec has given lower returns compared to its competitors.
Onyx Biotec has grown at ~-40.04% over the last 1yrs while peers have grown at a median rate of -32.72%

Onyx Biotec is not expensive.
Latest PE of Onyx Biotec is 12.7, while 3 year average PE is 27.18.
Also latest EV/EBITDA of Onyx Biotec is 5.92 while 3yr average is 11.52.

View FAQ's On Business

Growth Table

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Balance Sheet

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Cash Flow

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Quarterly Results

  • Onyx Biotec Ltd.
  • Cohance Lifesciences
  • JB Chem & Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Onyx Biotec Ltd. Financials

Balance sheet of Onyx Biotec is moderately strong.

Yes, The net debt of Onyx Biotec is increasing.
Latest net debt of Onyx Biotec is ₹8.54 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹4.59 Crs.

The profit is oscillating.
The profit of Onyx Biotec is ₹1.07 Crs for TTM, ₹4.95 Crs for Mar 2025 and ₹3.63 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Onyx Biotec latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech